Port Capital’s Novartis NVS Stock Holding History

Port Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,133	Closed	-$274K	–	79
2021 Q4	$274K	Hold	3,133	–	–	0.02%	71
2021 Q3	$256K	Sell	3,133 -200	-6%	-$18K	0.01%	73
2021 Q2	$304K	Hold	3,333	–	–	0.02%	71
2021 Q1	$285K	Sell	3,333 -900	-21%	-$80.8K	0.02%	76
2020 Q4	$400K	Hold	4,233	–	–	0.03%	72
2020 Q3	$368K	Hold	4,233	–	–	0.03%	66
2020 Q2	$370K	Hold	4,233	–	–	0.04%	62
2020 Q1	$349K	Sell	4,233 -100	-2%	-$8.92K	0.05%	63
2019 Q4	$410K	Hold	4,333	–	–	0.05%	77
2019 Q3	$377K	Sell	4,333 -1,000	-19%	-$89.8K	0.04%	91
2019 Q2	$487K	Sell	5,333 -2,739	-34%	-$232K	0.06%	85
2019 Q1	$695K	Sell	8,072 -1,266	-14%	-$102K	0.09%	73
2018 Q4	$718K	Hold	9,338	–	–	0.11%	75
2018 Q3	$721K	Buy	+9,338	New	+$690K	0.09%	97

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Port Capital's NVS Position: Q1 2022 in Review

Port Capital sold out of Novartis (NVS) in Q1 2022, closing a stake of 3,133 shares — an estimated $274K sold.

Port Capital first reported a position in NVS in Q3 2018 and held it in 14 quarters. The position peaked at $721K in Q3 2018. 1,136 funds tracked by Wall St. Rank hold NVS as of Q1 2022.

Port Capital reported no remaining Novartis position as of Q1 2022 after selling out during the quarter.
Port Capital sold 3,133 Novartis shares in Q1 2022, an estimated $274K.
Port Capital first reported a position in Novartis in Q3 2018 and held it in 14 quarters.
Port Capital's Novartis position peaked at $721K in Q3 2018.
1,136 funds tracked by Wall St. Rank held Novartis as of Q1 2022.

Based on Port Capital's 13F filing for Q1 2022, filed 16 May 2022.